Catalyst Wire Dossier Catalyst Wire Dossier

Cemsidomide

Cemsidomide · C4 Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Cemsidomide, covering 2026-03-12 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects [Phase 1]

See pricing